Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Sep 17, 2015 7:15 AM - Sep 18, 2015 4:15 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Patient Engagement in Benefit-Risk Assessment throughout the Life Cycle of Medical Products

Engage with patients, industry, and regulators to address the challenges of when and how to include patient perspectives in benefit-risk assessment of medical products.

Back to Agendas

Session 10: Summation and Call to Action

Session Chair(s)

Session Chair Invited

Manager

DIA, United States

Reflecting on the presentations and discussions of the past two days, a panel of stakeholders will highlight key learnings and agreements about including the patient perspective in benefit-risk assessment and decision-making through the medical product life cycle.
The closing Keynote Presentation will outline the vision and a call to action for better outcomes for patients through the collaborative efforts of all stakeholders.

Speaker(s)

Highlights of Key Conference Learnings and Agreements

Elaine H Morrato, DrPH, MPH

Loyola University Chicago, United States

Founding Dean, Parkinson School of Health Sciences and Public Health

Closing Keynote Speaker

Robert M. Califf, MD

FDA, United States

Commissioner

Barbara Lopez Kunz, MBA, MS, MSc

United States

Director | Advisor | CEO

Have an account?